Van Holle L - Search Results

1

Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine.

Tavares-Da-Silva F, Co MM, Dessart C, Hervé C, López-Fauqued M, Mahaux O, Van Holle L, Stegmann JU. Tavares-Da-Silva F, et al. Among authors: van holle l. Vaccine. 2020 Apr 16;38(18):3489-3500. doi: 10.1016/j.vaccine.2019.11.058. Epub 2019 Dec 7. Vaccine. 2020. PMID: 31818534 Free article.

2

Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology.

Tavares-Da-Silva F, Mahaux O, Van Holle L, Haguinet F, Seifert H, Stegmann JU. Tavares-Da-Silva F, et al. Among authors: van holle l. Drug Saf. 2020 Dec;43(12):1223-1234. doi: 10.1007/s40264-020-00989-2. Drug Saf. 2020. PMID: 32862397 Free PMC article.

3

Tree-based scan statistic - Application in manufacturing-related safety signal detection.

Mahaux O, Bauchau V, Zeinoun Z, Van Holle L. Mahaux O, et al. Among authors: van holle l. Vaccine. 2019 Jan 3;37(1):49-55. doi: 10.1016/j.vaccine.2018.11.044. Epub 2018 Nov 22. Vaccine. 2019. PMID: 30470642 Free article.

4

Signal detection based on time-to-onset: extending a new method from spontaneous reports to observational studies.

Van Holle L, Tavares Da Silva F, Bauchau V. Van Holle L, et al. Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):849-58. doi: 10.1002/pds.3669. Epub 2014 Jun 19. Pharmacoepidemiol Drug Saf. 2014. PMID: 24946233

5

Post-marketing monitoring of intussusception after rotavirus vaccination in Japan.

Bauchau V, Van Holle L, Mahaux O, Holl K, Sugiyama K, Buyse H. Bauchau V, et al. Among authors: van holle l. Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):765-70. doi: 10.1002/pds.3800. Epub 2015 May 27. Pharmacoepidemiol Drug Saf. 2015. PMID: 26013569 Free PMC article.

6

Investigating Reports of Complex Regional Pain Syndrome: An Analysis of HPV-16/18-Adjuvanted Vaccine Post-Licensure Data.

Huygen F, Verschueren K, McCabe C, Stegmann JU, Zima J, Mahaux O, Van Holle L, Angelo MG. Huygen F, et al. Among authors: van holle l. EBioMedicine. 2015 Jul 6;2(9):1114-21. doi: 10.1016/j.ebiom.2015.07.003. eCollection 2015 Sep. EBioMedicine. 2015. PMID: 26501109 Free PMC article.

7

Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines.

Mahaux O, Bauchau V, Van Holle L. Mahaux O, et al. Among authors: van holle l. Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):215-22. doi: 10.1002/pds.3918. Epub 2015 Nov 25. Pharmacoepidemiol Drug Saf. 2016. PMID: 26602179 Free PMC article. Review. No abstract available.

8

Use of logistic regression to combine two causality criteria for signal detection in vaccine spontaneous report data.

Van Holle L, Bauchau V. Van Holle L, et al. Drug Saf. 2014 Dec;37(12):1047-57. doi: 10.1007/s40264-014-0237-9. Drug Saf. 2014. PMID: 25395263 Free PMC article.

9

Using time-to-onset for detecting safety signals in spontaneous reports of adverse events following immunization: a proof of concept study.

Van Holle L, Zeinoun Z, Bauchau V, Verstraeten T. Van Holle L, et al. Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):603-10. doi: 10.1002/pds.3226. Epub 2012 Mar 1. Pharmacoepidemiol Drug Saf. 2012. PMID: 22383219

10

Modelling Hospitalisation Ratios for Febrile Convulsions and Severe Varicella Under Combined Measles, Mumps, Rubella, and Varicella (MMRV-Priorix-Tetra™) Compared to Separate MMR + V Vaccination.

Bauchau V, Van Holle L, Cohen C. Bauchau V, et al. Among authors: van holle l. Drug Saf. 2015 Nov;38(11):1095-102. doi: 10.1007/s40264-015-0326-4. Drug Saf. 2015. PMID: 26251259 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters